BVNRY
ADRs for Bavarian Nordic

847
Mkt Cap
$2.4B
Volume
434.00
52W High
$13.00
52W Low
$6.60
PE Ratio
6.53
BVNRY Fundamentals
Price
$10.32
Prev Close
$10.21
Open
$10.32
50D MA
$10.12
Beta
0.56
Avg. Volume
1,747.25
EPS (Annual)
$0.6115
P/B
1.16
Rev/Employee
$514,080.40
$1,769.31
Loading...
Loading...

About

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
1,611

Frequently Asked Questions

What is Market Cap of Bavarian Nordic A/S - ADR?
What is the 52-week high for Bavarian Nordic A/S - ADR?
What is the 52-week low for Bavarian Nordic A/S - ADR?
What is Bavarian Nordic A/S - ADR stock price today?
What was Bavarian Nordic A/S - ADR stock price yesterday?
What is the PE ratio of Bavarian Nordic A/S - ADR?
What is the Price-to-Book ratio of Bavarian Nordic A/S - ADR?
What is the 50-day moving average of Bavarian Nordic A/S - ADR?
How many employees does Bavarian Nordic A/S - ADR have?

Latest BVNRY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.